Skip to navigation bar Skip to breadcrumbs Skip to page content Skip to comments area
clear place holder Browse All Topics Envelope icon E-mail Updates Teal square Text size:  a A A
You are here: HomePublic Comments and NominationsOpportunity for Public CommentDraft Evidence Review : Draft Evidence Summary: Aspirin to Prevent Cancer

Draft Evidence Summary: Aspirin to Prevent Cancer

Draft Evidence Review for Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Preventive Medication

This opportunity for public comment expired on October 12, 2015 at 8:00 PM EST

Note: This is a Draft Evidence Review. This draft is distributed solely for the purpose of receiving public input. It has not been disseminated otherwise by the USPSTF. The final Evidence Review will be used to inform the USPSTF Recommendation Statement on this topic.

Recommendations made by the USPSTF are independent of the U.S. government. They should not be construed as an official position of the Agency for Healthcare Research and Quality or the U.S. Department of Health and Human Services.

Send Us Your Comments

In an effort to maintain a high level of transparency in our methods, we open our draft Evidence Reviews to a public comment period before we publish the final version.

Comment period is not open at this time.

In the interest of seeking feedback on the most current evidence available and providing all the evidence considered in its deliberation, the USPSTF is posting three Evidence Summaries for public comment and providing three Evidence Reviews and a Modeling Report as additional background information. While the systematic evidence reviews provide comprehensive details on the approach and the majority of the evidence, the Evidence Summaries provide the most up-to-date evidence. Therefore, the USPSTF is posting the Evidence Summaries for public comment. Evidence Summaries are manuscripts derived from the review that will be published in a peer-reviewed journal.

Current as of: September 2015

Internet Citation: Draft Evidence Review: Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Preventive Medication. U.S. Preventive Services Task Force. September 2015.
https://www.uspreventiveservicestaskforce.org/Page/Document/draft-evidence-summary-aspirin-to-prevent-cancer/aspirin-to-prevent-cardiovascular-disease-and-cancer

USPSTF Program Office   5600 Fishers Lane, Mail Stop 06E53A, Rockville, MD 20857